Europos Sąjunga - olandų - EMA (European Medicines Agency)

novartis europharm limited  - alpelisib - neoplasmata van de borst - antineoplastische middelen - piqray is geïndiceerd in combinatie met fulvestrant voor de behandeling van postmenopauzale vrouwen, en mannen, met hormoon-receptor (hr)-positief, humane epidermale groeifactorreceptor 2 (her2)-positieve, lokaal gevorderde of gemetastaseerde borstkanker met een pik3ca mutatie na ziekteprogressie volgende endocriene therapie als monotherapie (zie sectie 5.

Europos Sąjunga - olandų - EMA (European Medicines Agency)

pfizer europe ma eeig - glasdegib maleate - leukemie, myeloïde, acuut - antineoplastische middelen - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Europos Sąjunga - olandų - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastische middelen - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Europos Sąjunga - olandų - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastro-intestinale stromale tumoren - antineoplastische middelen - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Europos Sąjunga - olandų - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastische middelen - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Europos Sąjunga - olandų - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - carcinoom, niet-kleincellige long - antineoplastische middelen - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

hydrazinonicotinyl-tyr3-octreotidetrifluoracetaat 20 µg/flacon samenstelling overeenkomend met ; hydrazinonicotinyl-tyr3-octreotide 16,7 µg/flacon - kit voor radiofarmaceutisch preparaat - dinatriumwaterstoffosfaat 12-water (e 339) ; ethyleendiamine-n,n'-diazijnzuur ; mannitol (d-) (e 421) ; natriumhydroxide (e 524) ; stikstof (head space) (e 941) ; tindichloride 2-water (e 512) ; tricine ; zoutzuur (e 507)

Belgija - olandų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

narodowe centrum badan jadrowych pl - hynic-[d-phe1,tyr3-octreotide]-trifluoracetaat 20 µg - kit voor radiofarmaceutisch preparaat - 20 µg - hynic-[d-phe1,tyr3-octreotide]-trifluoracetaat 20 µg - technetium (99mtc) hynic-octreotide

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

centrafarm b.v. - rivastigminewaterstoftartraat samenstelling overeenkomend met; rivastigmine; - capsule, hard - rivastigmine

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

centrafarm b.v. - rivastigminewaterstoftartraat samenstelling overeenkomend met; rivastigmine; - capsule, hard - rivastigmine